Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4136826 | 0.85 | TSHR (0.46) | MEN1KMT2AALDH1A1CYP1A2 | |
| SCHEMBL4135711 | 0.80 | NPSR1 (0.32) | NPSR1MEN1KMT2ACYP2C19ALDH1A1 | |
| SCHEMBL21010740 | 0.79 | NPSR1 (0.39) | NPSR1MEN1KMT2ACYP2C19ALDH1A1 | |
| SCHEMBL4152881 | 0.78 | NPSR1 (0.32) | NPSR1MEN1KMT2ACYP2C19ALDH1A1 | |
| SCHEMBL10145890 | 0.73 | CYP2C19 (0.37) | NPSR1MEN1KMT2ACYP2C19ALDH1A1 | |
| SCHEMBL4136829 | 0.73 | TSHR (0.51) | NPSR1MEN1KMT2AALDH1A1CYP1A2 | |
| SCHEMBL25832660 | 0.72 | NPSR1 (0.36) | NPSR1MEN1KMT2ACYP2C19CYP2D6 | |
| SCHEMBL2546508 | 0.72 | NPSR1 (0.38) | NPSR1MEN1KMT2ACYP2C19ALDH1A1 | |
| SCHEMBL19798446 | 0.69 | ALDH1A1 (0.39) | NPSR1MEN1KMT2ACYP2C19ALDH1A1 | |
| SCHEMBL17571012 | 0.69 | NPSR1 (0.34) | NPSR1MEN1KMT2ACYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090137774-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC COMPONENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-1930327-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC COMPONENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137774-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC COMPONENT USING SAME | GJA1, CDH1, OR10J3 | NPSR1 2690/4885MEN1 3801/4885KMT2A 3147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.